Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2025
Deep Learning for Automated Measures of SUV and Molecular Tumor Volume in [<sup>68</sup>Ga]PSMA-11 or [<sup>18</sup>F]DCFPyL, [<sup>18</sup>F]FDG, and [<sup>177</sup>Lu]Lu-PSMA-617 Imaging with Global Threshold Regional Consensus Network
Price Jackson, James P Buteau, Lachlan McIntosh, et al.
BMJ Open
|
December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer
Nicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T
James P Buteau, Louise Kostos, Ramin Alipour, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Rodney J Hicks, Price Jackson, Grace Kong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
Prognostic Value of Initial Imaging and PSA Change with [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
David C Chen, James P Buteau, Nathan Papa, et al.
European Urology
|
October 27, 2023
Administering [<sup>177</sup>Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu S Eapen, James P Buteau, Price Jackson, et al.
Medical Image Analysis
|
September 30, 2022
Fast and Low-GPU-memory abdomen CT organ segmentation: The FLARE challenge
Jun Ma, Yao Zhang, Song Gu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2025
Deep Learning for Automated Measures of SUV and Molecular Tumor Volume in [<sup>68</sup>Ga]PSMA-11 or [<sup>18</sup>F]DCFPyL, [<sup>18</sup>F]FDG, and [<sup>177</sup>Lu]Lu-PSMA-617 Imaging with Global Threshold Regional Consensus Network
Price Jackson, James P Buteau, Lachlan McIntosh, et al.
BMJ Open
|
December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer
Nicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T
James P Buteau, Louise Kostos, Ramin Alipour, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Rodney J Hicks, Price Jackson, Grace Kong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
Prognostic Value of Initial Imaging and PSA Change with [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
David C Chen, James P Buteau, Nathan Papa, et al.
European Urology
|
October 27, 2023
Administering [<sup>177</sup>Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu S Eapen, James P Buteau, Price Jackson, et al.
Medical Image Analysis
|
September 30, 2022
Fast and Low-GPU-memory abdomen CT organ segmentation: The FLARE challenge
Jun Ma, Yao Zhang, Song Gu, et al.
Page
of 5